NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Numab Therapeutics AG
Numab Therapeutics AG
Novartis
Ikena Oncology
Ikena Oncology
Innovent Biologics (Suzhou) Co. Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network